Literature DB >> 8839387

Introduction of wild-type p53 gene downregulates the expression of H-ras gene and suppresses the growth of bladder cancer cells.

M Li1, F L Gu, W B Li, Y S Song, A R Zhou, Y L Guo.   

Abstract

Retroviral vectors were used to introduce the wild-type p53 gene into human bladder cancer cell lines BIU-87 and EJ, which express endogenous wt-p53 gene and have a mutation in H-ras gene. The expression of the exogenous wt-p53 gene in cells suppresses the growth of the bladder cancer cells in standard culture and in soft agar and blocks the cell cycle progression in G1. The BIU-87 and EJ cells developed tumors with average volumes of 6.53 cm3 and 6.61 cm3 in nude mice in 9 weeks after inoculation, while the cells transduced with wt-p53 gene failed to form tumors. The expression of H-ras gene in bladder cancer cells was reduced at mRNA level. These results suggest that the overexpression of the wt-p53 gene suppresses the expression of mutant H-ras gene and inhibits the tumor cell growth in vivo and in vitro.

Entities:  

Mesh:

Year:  1995        PMID: 8839387     DOI: 10.1007/bf00300019

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  16 in total

1.  p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.

Authors:  T Matozaki; C Sakamoto; T Suzuki; K Matsuda; T Uchida; O Nakano; K Wada; H Nishisaki; Y Konda; M Nagao
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

2.  Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer.

Authors:  D W Cai; T Mukhopadhyay; Y Liu; T Fujiwara; J A Roth
Journal:  Hum Gene Ther       Date:  1993-10       Impact factor: 5.695

3.  Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors.

Authors:  M Makos; B D Nelkin; R E Reiter; J R Gnarra; J Brooks; W Isaacs; M Linehan; S B Baylin
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

4.  Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions.

Authors:  T Takahashi; D Carbone; T Takahashi; M M Nau; T Hida; I Linnoila; R Ueda; J D Minna
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

5.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

6.  High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.

Authors:  M Furihata; K Inoue; Y Ohtsuki; H Hashimoto; N Terao; Y Fujita
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

7.  Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation.

Authors:  K A Han; M F Kulesz-Martin
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

8.  Chromosome 17p deletions and p53 mutations in renal cell carcinoma.

Authors:  R E Reiter; P Anglard; S Liu; J R Gnarra; W M Linehan
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

9.  Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

Authors:  C J Kemp; L A Donehower; A Bradley; A Balmain
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

10.  p53 abnormalities in different subtypes of human sarcomas.

Authors:  A Andreassen; T Oyjord; E Hovig; R Holm; V A Flørenes; J M Nesland; O Myklebost; J Høie; O S Bruland; A L Børresen
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

View more
  2 in total

1.  Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway.

Authors:  Zhengcun Wu; Chengxing Xia; Chao Zhang; Donghong Tang; Feineng Liu; Yitian Ou; Jiahong Gao; Hongkun Yi; Delin Yang; Kaili Ma
Journal:  Cancer Gene Ther       Date:  2022-01-21       Impact factor: 5.854

2.  A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.

Authors:  Xiaofeng Yang; Fan Zhang; Junqian Luo; Jianzhi Pang; Sanhua Yan; Fang Luo; Jiehao Liu; Wei Wang; Yongping Cui; Xixi Su
Journal:  Oncol Rep       Date:  2016-05-23       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.